Germany’s Federal Ministry of Health (BMG) withdraws draft amendment to cannabis program

ICBC reports

A recently published draft amendment from Germany’s Federal Ministry of Health (BMG) that would dramatically overhaul the nation’s medical cannabis program was originally scheduled to be part of a Federal Cabinet meeting earlier this month, but was reportedly withdrawn. That has, in turn, created speculation as to why it was withdrawn from the meeting’s agenda.

“With the entry into force of the Medical Cannabis Act (MedCanG) at the beginning of April 2024, the legislature has reorganized the previous legal situation: Medical cannabis has been enshrined in a separate set of rules beyond the Narcotics Act, thus placing its medical use on a par with other prescription drugs.” reported LTO in its local coverage.

“However, the Federal Ministry of Health (BMG) already intends to amend the MedCanG and has submitted a preliminary draft bill for this purpose. Until a few days ago, this bill was also on the draft agenda for the Federal Cabinet meeting on September 10, but was subsequently withdrawn. Whether it will be revised again remains unclear.” the outlet also reported.

The draft amendment has received considerable pushback from Germany’s medical cannabis community. As drafted, the measure would:

  • Require mandatory in-person doctor consultations
  • Ban mail-order medical cannabis dispensing
  • Implement stricter rules for medical cannabis prescriptions

“The SPD emphasized that barrier-free, local care for patients must be guaranteed…” stated the German Cannabis Business Association in its recent newsletter (translated from German to English). “Online prescriptions should not be permitted without restrictions, but at the same time, a balanced regulation is necessary. Whether and in what form the Federal Ministry of Health will refine the draft remains open. Negotiations on changes to the Medical Cannabis Act are continuing within the coalition, reports LTO reporter Hasso Suliak on X.”

Read the full report

Harmful German Medical Cannabis Amendment Withdrawn From Agenda

 

Also as reported by the German Cannabis Industry Assoc’s Newsletter

Telemedicine and shipping of medical cannabis: BMG draft under revision

2025-09-10 | The Federal Ministry of Health (BMG) has withdrawn a draft amendment to the Medical Cannabis Act (MedCanG) from the Federal Cabinet’s agenda that would have introduced a ban on shipping and online prescriptions for cannabis flowers, according to LTO. Speculation is ongoing about a possible revision of the draft.
Attorney Franziska Katterbach expressed doubts in the LTO article as to whether a blanket ban would be proportionate, compatible with European law, and constitutional. Criticism was particularly directed at the disadvantage for German doctors compared to colleagues in other EU countries where telemedicine remains permitted.
The SPD emphasized that barrier-free, local patient care must be ensured, according to Pharmazeutische Zeitung. While online prescriptions should not be unrestricted, a balanced regulation was necessary. It remains unclear whether and how the BMG will revise the draft. Negotiations within the coalition on changes to the Medical Cannabis Act are ongoing, reports LTO journalist Hasso Suliak on X. The SPD parliamentary group generally supports the project, health politician Dr. Pantazis (SPD, MP) told LTO. According to Matthias Mieves (SPD, MP) on Abgeordnetenwatch, the bill responds to an increase in private prescriptions via online platforms without doctor contact and aims to prevent potential misuse.
Parliamentary State Secretary Georg Kippels (CDU), responding on behalf of the federal government to questions from Left Party MP Sascha Wagner (Bundestag Printed Paper 21/1482), stated that the changes would have no impact on tax revenues. The goal of the draft was to specify the prescription and dispensing of medical cannabis following personal doctor contact and to strengthen patient safety. Non-medical use remains covered by the Cannabis Consumption Act (KCanG), which will be evaluated separately. Carmen Wegge (SPD, MP) said on Abgeordnetenwatch that the issue is expected to be discussed in the Cabinet in October.

Get Connected

Karma Koala Podcast

Top Marijuana Blog